Literature DB >> 26062862

Effects of parathyroid hormone dosage and schedule on bone regeneration.

Katsuyoshi Tsunori1.   

Abstract

This study investigated the effects of administration of parathyroid hormone (PTH) at different dosages and schedules on bone regeneration in critical-size bone defects in rat calvariae. After calvarial defects had been prepared in 50 rats, they were divided into five treatment groups: 15 µg/kg PTH daily (PTH-15), 35 µg/kg PTH three times per week (PTH-35), 105 µg/kg once per week (PTH-105-1), 105 µg/kg three times per week (PTH-105-3), and controls given vehicle alone. Bone regeneration was evaluated radiographically using micro-computed tomography (micro-CT) or histologically. The amount of newly generated bone in the calvarial defects was found to be significantly greater in the PTH groups than in the control group, and did not differ significantly among the PTH-15, PTH-35, and PTH-105-1 groups, whereas the PTH-105-3 group showed a significantly greater degree of new bone formation than the other PTH groups. It appeared that a higher dose of PTH stimulated a greater degree of bone regeneration in this experimental setting. The present results also suggest that the total dose of PTH administered is significantly related to the amount of bone regenerated within a defined period, indicating that less frequent administration of PTH might be a feasible protocol for bone regeneration therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26062862     DOI: 10.2334/josnusd.57.131

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  6 in total

1.  Do antiosteoporotic drugs improve bone regeneration in vivo?

Authors:  Maximilian Leiblein; Dirk Henrich; Florian Fervers; Kerstin Kontradowitz; Ingo Marzi; Caroline Seebach
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-26       Impact factor: 3.693

2.  Enhanced bone tissue regeneration with hydrogel-based scaffolds by embedding parathyroid hormone in mesoporous bioactive glass.

Authors:  Mariane Beatriz Sordi; Márcio Celso Fredel; Ariadne Cristiane Cabral da Cruz; Paul Thomas Sharpe; Ricardo de Souza Magini
Journal:  Clin Oral Investig       Date:  2022-08-26       Impact factor: 3.606

3.  Histological and histomorphometric aspects of continual intermittent parathyroid hormone administration on osseointegration in osteoporosis rabbit model.

Authors:  Yoshifumi Oki; Kazuya Doi; Reiko Kobatake; Yusuke Makihara; Koji Morita; Takayasu Kubo; Kazuhiro Tsuga
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

4.  Triweekly administration of parathyroid hormone (1-34) accelerates bone healing in a rat refractory fracture model.

Authors:  Yohei Kumabe; Sang Yang Lee; Takahiro Waki; Takashi Iwakura; Shunsuke Takahara; Michio Arakura; Yu Kuroiwa; Tomoaki Fukui; Tomoyuki Matsumoto; Takehiko Matsushita; Kotaro Nishida; Ryosuke Kuroda; Takahiro Niikura
Journal:  BMC Musculoskelet Disord       Date:  2017-12-21       Impact factor: 2.362

5.  Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model.

Authors:  Yoshifumi Oki; Kazuya Doi; Yusuke Makihara; Reiko Kobatake; Takayasu Kubo; Kazuhiro Tsuga
Journal:  J Appl Oral Sci       Date:  2017 Sep-Oct       Impact factor: 2.698

6.  Locally administrated single-dose teriparatide affects critical-size rabbit calvarial defects: A histological, histomorphometric and micro-CT study.

Authors:  Taha Özer; Özgür Başlarlı; Alper Aktaş; Emre Barış; Hakan Hamdi Çelik; Mert Ocak
Journal:  Acta Orthop Traumatol Turc       Date:  2019-09-14       Impact factor: 1.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.